Randomized phase III study of capecitabine, oxaliplatin and bevacizumab with or without cetuximab in advanced colorectal cancer CAIRO2 study of the Dutch.
Bevacizumab in combination with capecitabine for the first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): Results of a randomized.
CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)
Objectives
Réunion Maladie de Fanconi 6 Octobre 2012
Professor Anwar Sheikha MD, FRCP, FRCPath., FCAP, FRCPA, FRCPI, FACP
Disclosures
1 april sovannaroth
Upper respiratory tract infections Rasool Soltani, Pharm.D., BCPS Assistant professor of Clinical Pharmacy Isfahan University of Medical Sciences.
RespirationRespiration Elisa A. Mancuso RNC, MS, FNS Professor of Nursing.
Diseases of Nervous system
Document
